MedTrace Logo

Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy

NCT05761912 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 464

Last updated 2026-01-22

No results posted yet for this study

Summary

To predict prostate cancer by ultrasound radiomics in ultrasound fusion prostate targeted biopsy.

Conditions

Interventions

DIAGNOSTIC_TEST

Targeted biopsy

For the high-risk targets identified by the radiomics model, perform targeted biopsy under ultrasound fusion.

Sponsors & Collaborators

  • Wu Jieping Medical Foundation

    collaborator OTHER

  • Shanghai Municipal Commission of Health and Family Planning

    collaborator OTHER

  • Shanghai Minhang Central Hospital

    lead OTHER

Principal Investigators

  • Jiaqi Huang · Minhang Hospital, Fudan University

Eligibility

Min Age
55 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-23
Primary Completion
2026-02-15
Completion
2026-02-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05761912 on ClinicalTrials.gov